Research Tool Bench

Systematic Review Software Pricing & Feature Tracker (2026)

Last updated 2026-08-16

Prices below come only from each vendor's own pricing page, with the date we checked. We do not take prices from third-party review sites, because those are frequently out of date in the direction that flatters the tool.

What this table is notThis is Layer C of our evidence: prices and stated limits. It says nothing about how well a tool screens. Performance lives in the benchmark, under aseparate protocol, and the two are never merged into one score.

Plans an individual can buy directly

ToolPlanPriceIntended buyerStated limits
ASReview LABOpen sourceFreeindividualNo licence fee; runs locally
RayyanFreeFreeindividual3 active reviews, 2 free reviewers, duplicate detection, AI predictions
RayyanEssentialUS$4.99/month (billed annually)individualPRISMA diagrams, 5 free reviewers, auto-resolve duplicates
RayyanAdvancedUS$8.33/month (billed annually)team9 active reviews, 10 free reviewers, PICO data extraction
CovidenceSingleUS$339/yearindividualOne review, unlimited collaborators
CovidencePackageUS$907/yearteamUp to 3 reviews, unlimited collaborators
CovidenceOrganizationsCustom quoteinstitutionCustom quote; unlimited reviews and users

All rows verified 2026-08-16 against vendor pricing pages.

The thing most comparisons leave out

The headline price is rarely what decides the purchase. What decides it is the limit attached to it — how many reviews a plan covers, how many reviewers you can invite without paying more, and how large a trial you get before committing.

Those limits also determine what we ourselves can test. A record-limited individual trial makes a full-corpus benchmark run impossible, so the affected tool carries an empty performance cell and a stated reason rather than an estimate. We would rather show you the boundary than paper over it.

Sources